Methods of treating cancer using an fpt inhibitor and anti...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 31/454 (2006.01) A61K 31/4545 (2006.01) A61K 31/7068 (2006.01) A61K 33/24 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2468839

Disclosed is a use of an FPT inhibitor for the manufacture of a medicament for the treatment of cancer. The treatment comprises administering a therapeutically effective amount of the medicament and therapeutically effective amounts of one or more antineoplastic agents. The cancers treated include non small cell lung cancer, CML, AML, non-Hodgkin s lymphoma and multiple myeloma.

L'invention concerne une utilisation d'un inhibiteur de FPT pour la production d'un médicament destiné au traitement du cancer. Ledit traitement consiste à administrer une dose thérapeutiquement efficace dudit médicament et des doses thérapeutiquement efficaces d'un ou de plusieurs agents néoplasiques. Parmi les cancers traités, on peut citer le cancer du poumon non à petites cellules, la leucémie myéloïde chronique, la leucémie myéloïde aiguë, le lymphome non Hodgkinien et le myélome multiple.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treating cancer using an fpt inhibitor and anti... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating cancer using an fpt inhibitor and anti..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating cancer using an fpt inhibitor and anti... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1537928

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.